Latest News

The donation formed part of GHANCOY 5’s planned civil-military cooperation activities, which seek to strengthen relations between the military contingent and local communities.

The allocation forms part of an initial release of 70,000 Ervebo doses to the Democratic Republic of the Congo (DRC).

The researchers focused on polygenic risk scores, which combine the effects of multiple genetic variants to estimate a person’s inherited susceptibility to a disease. However, existing methods may overlook genetic information associated with disease risk.

The consignment, which originated in neighboring Sierra Leone, contained 44 cartons of Reality Extra D, a pharmaceutical product containing diclofenac sodium 50 mg.

Researchers will need about 55,000 participants to support currently active studies.

The arrangement gives Ona Therapeutics access to WuXi XDC’s capabilities across ADC development and manufacturing as it advances the candidate towards clinical development.

The ACUVUE OASYS MAX 2 Week lens is part of the wider ACUVUE OASYS MAX portfolio, which J&J developed to provide advanced options for people who use reusable contact lenses.

Novadip will use the proceeds to advance NVD003, its lead autologous cell-based therapy, through late-stage clinical development and regulatory preparation.

HAKIKA responds to concerns raised by public, private and faith-based healthcare providers over tariffs, claims processing, payment delays, pre-authorization, system reliability and empanelment.

Patients have an average lifespan of about 15 years, while an estimated 3,000 to 5,000 people in commercially accessible markets live with the condition.